SCHEMBL887090

SCHEMBL887090

CCO[C](OC(C)=O)OC(C)=O

nearest known ligand 0.60

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.60
HSD17B10 Q99714 2/20 0.60
LMNA P02545 1/20 0.60
SOAT1 P35610 1/20 0.50
TSHR P16473 3/20 0.47
ALOX15 P16050 1/20 0.43
MGAM O43451 1/20 0.43
GAA P10253 1/20 0.43
SI P14410 1/20 0.43
MGAM2 Q2M2H8 1/20 0.43
TDP1 Q9NUW8 2/20 0.40
TRPA1 O75762 1/20 0.40
GLO1 Q04760 1/20 0.39
HCAR2 Q8TDS4 1/20 0.36
MAPT P10636 1/20 0.35
NPSR1 Q6W5P4 1/20 0.34
CYP1A2 P05177 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6437696 0.94 ALDH1A1 (0.60) ALDH1A1HSD17B10LMNASOAT1TSHR
Ethyl Acetate SCHEMBL10620330 0.80 ALDH1A1 (0.82) ALDH1A1HSD17B10LMNASOAT1TSHR
SCHEMBL11808669 0.78 ALDH1A1 (0.60) ALDH1A1HSD17B10LMNASOAT1TSHR
SCHEMBL6314407 0.78 ALDH1A1 (0.72) ALDH1A1HSD17B10LMNASOAT1TSHR
SCHEMBL2161093 0.78
SCHEMBL2308025 0.76 SOAT1 (0.70) ALDH1A1HSD17B10LMNASOAT1TSHR
Diethyl Pyrocarbonate SCHEMBL8342707 0.76 SOAT1 (0.79) ALDH1A1HSD17B10LMNASOAT1TSHR
SCHEMBL8332085 0.76 ALDH1A1 (0.57) ALDH1A1HSD17B10LMNASOAT1TSHR
SCHEMBL15413048 0.76 ALDH1A1 (0.57) ALDH1A1HSD17B10LMNASOAT1TSHR
SCHEMBL27651053 0.76 SOAT1 (0.70) ALDH1A1HSD17B10LMNASOAT1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120107272-A1 SYNTHETIC METHODS AND DERIVATIVES OF TRIPHOSPHATE OLIGONUCLEOTIDES ALNYLAM PHARMACEUTICALS, INC. (US) 2012-05-03 US disclosed
EP-2344514-A2 SYNTHETIC METHODS AND DERIVATIVES OF TRIPHOSPHATE OLIGONUCLEOTIDES Alnylam Pharmaceuticals Inc. (US) 2011-07-20 EP disclosed
WO-2010028079-A2 SYNTHETIC METHODS AND DERIVATIVES OF TRIPHOSPHATE OLIGONUCLEOTIDES ALNYLAM PHARMACEUTICALS, INC (US) 2010-03-11 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120107272-A1 SYNTHETIC METHODS AND DERIVATIVES OF TRIPHOSPHATE OLIGONUCLEOTIDES IFNAR1, DDX18, STING1 ALDH1A1 1536/4885HSD17B10 4303/4885LMNA 4707/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.